| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Two clinical trials that used Falcidin (Cosmos Ltd., Nairobi, Kenya), the antifolate combination of pyrimethamine/sulfadoxine (PM/SD), as treatment for non-severe falciparum malaria in children at Kilifi, Kenya in 1987-1988 and 1993-1995 have presented an opportunity to assess in vitro the susceptibility trend of Plasmodium falciparum to PM and SD over time on the Kenya coast. The first set of isolates was collected prior to the introduction of PM/SD into the Kenya Medical Research Institute/Wellcome Trust Research unit while the second set was taken soon after PM/SD was introduced in the study area as the first-line treatment drug for uncomplicated falciparum malaria. In the first trial, 69 isolates collected before and after treatment of malaria with PM/SD were tested directly in the field for susceptibility to PM and SD using the standard in vitro micro-test technique, with minimal levels of folate. In the second trial, 97 isolates similarly collected were adapted to culture, and tested as described elsewhere. In both studies, PM and SD susceptibility tests were done separately. There was a highly significant decrease (P < 0.01) in the in vitro sensitivity of P. falciparum isolates to PM and SD between the two trials. In the first trial, the isolates were either sensitive to both PM and SD or resistant to PM and sensitive to SD. During the second trial, isolates were either resistant to PM and sensitive to SD or resistant to both drugs. These results are important in estimating the useful therapeutic life (UTL) of PM/SD in this area and in identifying alternative antifolate drugs.
This article has been cited by other articles:
|
|
 |
|
  E. Ochong, D. J. Bell, D. J. Johnson, U. D'Alessandro, M. Mulenga, S. Muangnoicharoen, J.-P. Van Geertruyden, P. A. Winstanley, P. G. Bray, S. A. Ward, et al. Plasmodium falciparum Strains Harboring Dihydrofolate Reductase with the I164L Mutation Are Absent in Malawi and Zambia Even under Antifolate Drug Pressure Antimicrob. Agents Chemother., November 1, 2008; 52(11): 3883 - 3888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. N. Nantulya, J. F. Kengeya-Kayondo, and O. A. T. Ogundahunsi Research Themes and Advances in Malaria Research Capacity Made by the Multilateral Initiative on Malaria Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 303 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. McCollum, K. Mueller, L. Villegas, V. Udhayakumar, and A. A. Escalante Common Origin and Fixation of Plasmodium falciparum dhfr and dhps Mutations Associated with Sulfadoxine-Pyrimethamine Resistance in a Low-Transmission Area in South America Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2085 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. RUNGSIHIRUNRAT, K. NA-BANGCHANG, V. N. HAWKINS, M. MUNGTHIN, and C. H. SIBLEY SENSITIVITY TO ANTIFOLATES AND GENETIC ANALYSIS OF PLASMODIUM VIVAX ISOLATES FROM THAILAND Am J Trop Med Hyg, June 1, 2007; 76(6): 1057 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Marks, J. Evans, C. G. Meyer, E. N. Browne, C. Flessner, V. von Kalckreuth, T. A. Eggelte, R. D. Horstmann, and J. May High Prevalence of Markers for Sulfadoxine and Pyrimethamine Resistance in Plasmodium falciparum in the Absence of Drug Pressure in the Ashanti Region of Ghana Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1101 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. VREUGDENHIL, F. Y. SCHEPER, S. R. HOOGSTRAATTE, M. SMOLDERS, S. GIKUNDA, F. G. COBELENS, and P. A. KAGER COMPARISON OF THE PARASITOLOGIC EFFICACY OF AMODIAQUINE AND SULFADOXINE-PYRIMETHAMINE IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA IN THE BUNGOMA DISTRICT OF WESTERN KENYA Am J Trop Med Hyg, November 1, 2004; 71(5): 537 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mbaisi, P. Liyala, F. Eyase, R. Achilla, H. Akala, J. Wangui, J. Mwangi, F. Osuna, U. Alam, B. L. Smoak, et al. Drug Susceptibility and Genetic Evaluation of Plasmodium falciparum Isolates Obtained in Four Distinct Geographical Regions of Kenya Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3598 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Gatton, L. B Martin, and Q. Cheng Evolution of Resistance to Sulfadoxine-Pyrimethamine in Plasmodium falciparum Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2116 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. KYABAYINZE, A. CATTAMANCHI, M. R. KAMYA, P. J. ROSENTHAL, and G. DORSEY VALIDATION OF A SIMPLIFIED METHOD FOR USING MOLECULAR MARKERS TO PREDICT SULFADOXINE-PYRIMETHAMINE TREATMENT FAILURE IN AFRICAN CHILDREN WITH FALCIPARUM MALARIA Am J Trop Med Hyg, September 1, 2003; 69(3): 247 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Pearce, C. Drakeley, D. Chandramohan, F. Mosha, and C. Roper Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1347 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. PHILLIPS-HOWARD, K. A. WANNEMUEHLER, F. O. TER KUILE, W. A. HAWLEY, M. S. KOLCZAK, A. ODHACHA, J. M. VULULE, and B. L. NAHLEN DIAGNOSTIC AND PRESCRIBING PRACTICES IN PERIPHERAL HEALTH FACILITIES IN RURAL WESTERN KENYA Am J Trop Med Hyg, April 1, 2003; 68(90040): 44 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. GASASIRA, G. DORSEY, B. NZARUBARA, S. G. STAEDKE, A. NASSALI, P. J. ROSENTHAL, and M. R. KAMYA COMPARATIVE EFFICACY OF AMINOQUINOLINE-ANTIFOLATE COMBINATIONS FOR THE TREATMENT OF UNCOMPLICATED FALCIPARUM MALARIA IN KAMPALA, UGANDA Am J Trop Med Hyg, February 1, 2003; 68(2): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
